Advertisement

Impact of Dietary Intake on Bone Turnover in Patients with Phenylalanine Hydroxylase Deficiency

  • Kathryn E. CoakleyEmail author
  • Eric I. Felner
  • Vin Tangpricha
  • Peter W. F. Wilson
  • Rani H. Singh
Research Report
Part of the JIMD Reports book series (JIMD, volume 36)

Abstract

Phenylalanine hydroxylase (PAH) deficiency is a genetic disorder characterized by deficiency of the PAH enzyme. Patients follow a phenylalanine-restricted diet low in intact protein, and must consume synthetic medical food (MF) to supply phenylalanine-free protein. We assessed relationships between dietary intake and nutrient source (food or MF) on bone mineral density (BMD) and bone turnover markers (BTM) in PAH deficiency. Blood from 44 fasted females 11–52 years of age was analyzed for plasma phenylalanine, serum BTM [CTx (resorption), P1NP (formation)], vitamin D, and parathyroid hormone (PTH). BTM ratios were calculated to assess resorption relative to formation (CTx/P1NP). Dual energy X-ray absorptiometry measured total BMD and age-matched Z-scores. Three-day food records were analyzed for total nutrient intake, nutrients by source (food, MF), and compliance with MF prescription. Spearman’s partial coefficients (adjusted for age, BMI, energy intake, blood phenylalanine) assessed correlations. All had normal BMD for age (Z-score >−2). Sixty-four percent had high resorption and normal formation indicating uncoupled bone turnover. CTx/P1NP was positively associated with food phenylalanine (r2 = 0.39; p-value = 0.017), energy (r2 = 0.41; p-value = 0.011) and zinc (r2 = 0.41; p-value = 0.014). CTx/P1NP was negatively associated with MF fat (r2 = −0.44; p-value = 0.008), MF compliance (r2 = −0.34; p-value = 0.056), and positively with food sodium (r2 = 0.43; p-value = 0.014). CTx/P1NP decreased significantly with age (p-value = 0.002) and higher PTH (p-value = 0.0002). Phenylalanine was not correlated with any bone indicator. Females with PAH deficiency had normal BMD but elevated BTM, particularly resorption. More favorable ratios were associated with nutrients from MF and compliance. Younger females had less favorable BTM ratios. Promoting micronutrient intake through compliance with MF may impact bone metabolism in patients with PAH deficiency.

Synopsis: Bone mineral density was normal in 44 females with PAH deficiency; however, bone turnover markers suggested uncoupling of bone resorption and formation, particularly in younger patients. Adequate nutrient intake from medical food and overall medical food compliance may positively impact bone turnover.

Keywords

Bone metabolism Bone mineral density Bone turnover markers Dietary intake Medical food Phenylalanine hydroxylase deficiency 

Notes

Acknowledgments

We would like to thank the National PKU Alliance for support for DXA scans, Immunodiagnostic Systems (IDS) for support for bone turnover marker measurement, and the Atlanta Clinical and Translational Science Institute (ACTSI) for general study support including staff and facilities at Emory University Hospital’s Clinical Research Network and Children’s Hospital of Atlanta’s Pediatric Research Center.

References

  1. Adami S, Bianchi G, Brandi ML et al (2008) Determinants of bone turnover markers in healthy premenopausal women. Calcif Tissue Int 82:341–347CrossRefPubMedGoogle Scholar
  2. Blau N, van Spronsen FJ, Levy HL (2010) Phenylketonuria. Lancet 376:1417–1427CrossRefPubMedGoogle Scholar
  3. Burch J, Rice S, Yang H et al (2014) Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups. Health Technol Assess 18:1–180CrossRefPubMedPubMedCentralGoogle Scholar
  4. Burgard P (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159(Suppl 2):S74–S79CrossRefPubMedGoogle Scholar
  5. Camp KM, Lloyd-Puryear MA, Huntington KL (2012) Nutritional treatment for inborn errors of metabolism: indications, regulations, and availability of medical foods and dietary supplements using phenylketonuria as an example. Mol Genet Metab 107:3–9CrossRefPubMedPubMedCentralGoogle Scholar
  6. Carson DJ, Greeves LG, Sweeney LE, Crone MD (1990) Osteopenia and phenylketonuria. Pediatr Radiol 20:598–599CrossRefPubMedGoogle Scholar
  7. Cavalier E, Carlisi A, Rousselle O, Ferracini R, Chapelle J (2012a) Analytical verification of the IDS-iSYS intact amino-terminal Propeptide of Type I Procollagen (PINP) automated immunoassay. Department of Clinical Chemistry, University of Liège, CHU Sart-Tilman, Liège, BelgiumGoogle Scholar
  8. Cavalier E, Carlisi A, Rousselle O, Ferrante N, Chapelle J (2012b) Analytical performance of the IDS-iSYS CrossLaps (CTX-I) automated immunoassay. The American Association for Clinical Chemistry, Los AngelesGoogle Scholar
  9. Chevalley T, Bonjour JP, van Rietbergen B, Rizzoli R, Ferrari S (2012) Fractures in healthy females followed from childhood to early adulthood are associated with later menarcheal age and with impaired bone microstructure at peak bone mass. J Clin Endocrinol Metab 97:4174–4181CrossRefPubMedGoogle Scholar
  10. Demirdas S, Coakley KE, Bisschop PH, Hollak CE, Bosch AM, Singh RH (2015) Bone health in phenylketonuria: a systematic review and meta-analysis. Orphanet J Rare Dis 10:17CrossRefPubMedPubMedCentralGoogle Scholar
  11. Enns GM, Koch R, Brumm V, Blakely E, Suter R, Jurecki E (2010) Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence. Mol Genet Metab 101:99–109CrossRefPubMedGoogle Scholar
  12. Evans S, Daly A, MacDonald J et al (2014) The micronutrient status of patients with phenylketonuria on dietary treatment: an ongoing challenge. Ann Nutr Metab 65:42–48CrossRefPubMedGoogle Scholar
  13. Faje AT, Fazeli PK, Miller KK et al (2014) Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa. Int J Eat Disord 47:458–466CrossRefPubMedPubMedCentralGoogle Scholar
  14. Fardellone P, Sejourne A, Paccou J, Goeb V (2014) Bone remodelling markers in rheumatoid arthritis. Mediators Inflamm 2014:484280CrossRefPubMedPubMedCentralGoogle Scholar
  15. Faulkner KG, McClung MR, Coleman LJ, Kingston-Sandahl E (1994) Quantitative ultrasound of the heel: correlation with densitometric measurements at different skeletal sites. Osteoporos Int 4:42–47CrossRefPubMedGoogle Scholar
  16. Feinberg SB, Fisch RO (1962) Roentgenologic findings in growing long bones in phenylketonuria. Preliminary study. Radiology 78:394–398CrossRefPubMedGoogle Scholar
  17. Geiger KE, Koeller DM, Harding CO, Huntington KL, Gillingham MB (2016) Normal vitamin D levels and bone mineral density among children with inborn errors of metabolism consuming medical food-based diets. Nutr Res 36:101–108CrossRefPubMedGoogle Scholar
  18. Hansen KE, Ney D (2014) A systematic review of bone mineral density and fractures in phenylketonuria. J Inherit Metab Dis 37:875–880CrossRefPubMedPubMedCentralGoogle Scholar
  19. Hedstrom EM, Svensson O, Bergstrom U, Michno P (2010) Epidemiology of fractures in children and adolescents. Acta Orthop 81:148–153CrossRefPubMedPubMedCentralGoogle Scholar
  20. Hillman L, Schlotzhauer C, Lee D et al (1996) Decreased bone mineralization in children with phenylketonuria under treatment. Eur J Pediatr 155(Suppl 1):S148–S152CrossRefPubMedGoogle Scholar
  21. Institute of Medicine (U.S.) Subcommittee on Interpretation and Uses of Dietary Reference Intakes, Institute of Medicine (U.S.) Subcommittee on Upper Reference Levels of Nutrients, Institute of Medicine (U.S.) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes (2000) Dietary reference intakes. Applications in dietary assessment: a report of the Subcommittees on Interpretation and Uses of Dietary Reference Intakes and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine, Washington: National Academy Press.Google Scholar
  22. IOM (2005) Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. National Academies Press, WashingtonGoogle Scholar
  23. ISCD (2013a) Skeletal health assessment in children and adolescents (males and females ages 5-19). Middletown, International Society for Clinical DensitometryGoogle Scholar
  24. ISCD (2013b) Skeletal health assessment in children from infancy to adolescence. ISCD, MiddletownGoogle Scholar
  25. Johansson H, Oden A, Kanis JA et al (2014) A meta-analysis of reference markers of bone turnover for prediction of fracture. Calcif Tissue Int 94:560–567CrossRefPubMedGoogle Scholar
  26. Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929–1936CrossRefPubMedGoogle Scholar
  27. Koura HM, Abdallah Ismail N, Kamel AF, Ahmed AM, Saad-Hussein A, Effat LK (2011) A long-term study of bone mineral density in patients with phenylketonuria under diet therapy. Arch Med Sci 7:493–500CrossRefPubMedPubMedCentralGoogle Scholar
  28. Lage S, Bueno M, Andrade F et al (2010) Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density. J Inherit Metab Dis 33(Suppl 3):S363–S371CrossRefPubMedGoogle Scholar
  29. Lammardo AM, Robert M, Rocha JC et al (2013) Main issues in micronutrient supplementation in phenylketonuria. Mol Genet Metab 110(Suppl):S1–S5CrossRefPubMedGoogle Scholar
  30. Lee J, Vasikaran S (2012) Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis. Ann Lab Med 32:105–112CrossRefPubMedPubMedCentralGoogle Scholar
  31. Levine MA (2012) Assessing bone health in children and adolescents. Indian J Endocrinol Metab 16:S205–S212PubMedPubMedCentralGoogle Scholar
  32. McMurry MP, Chan GM, Leonard CO, Ernst SL (1992) Bone mineral status in children with phenylketonuria – relationship to nutritional intake and phenylalanine control. Am J Clin Nutr 55:997–1004PubMedGoogle Scholar
  33. Modan-Moses D, Vered I, Schwartz G et al (2007) Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis 30:202–208CrossRefPubMedGoogle Scholar
  34. Morovat A, Catchpole A, Meurisse A et al (2013) IDS iSYS automated intact procollagen-1-N-terminus pro-peptide assay: method evaluation and reference intervals in adults and children. Clin Chem Lab Med 51:2009–2018CrossRefPubMedGoogle Scholar
  35. Naylor K, Eastell R (2012) Bone turnover markers: use in osteoporosis. Nat Rev Rheumatol 8:379–389CrossRefPubMedGoogle Scholar
  36. NCC (2011) Nutrition Data System for Research (NDSR). University of Minnesota, MinneapolisGoogle Scholar
  37. Perez-Duenas B, Cambra FJ, Vilaseca MA, Lambruschini N, Campistol J, Camacho JA (2002) New approach to osteopenia in phenylketonuric patients. Acta Paediatr 91:899–904CrossRefPubMedGoogle Scholar
  38. Qvist P, Christgau S, Pedersen BJ, Schlemmer A, Christiansen C (2002) Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 31:57–61CrossRefPubMedGoogle Scholar
  39. Roato I, Porta F, Mussa A et al (2010) Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase. PLoS One 5:e14167CrossRefPubMedPubMedCentralGoogle Scholar
  40. Ross AC (2011) The 2011 report on dietary reference intakes for calcium and vitamin D. Public Health Nutr 14:938–939CrossRefPubMedGoogle Scholar
  41. Ryan-Harshman M, Aldoori W (2006) New dietary reference intakes for macronutrients and fibre. Can Fam Physician 52:177–179PubMedPubMedCentralGoogle Scholar
  42. SAS (2013) Statistical Analysis Software (SAS). SAS Institute, CaryGoogle Scholar
  43. Singh RH, Rohr F, Frazier D et al (2014) Recommendations for the nutrition management of phenylalanine hydroxylase deficiency. Genet Med 16:121–131CrossRefPubMedPubMedCentralGoogle Scholar
  44. Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504–1508CrossRefPubMedGoogle Scholar
  45. Wheater G, Elshahaly M, Tuck SP, Datta HK, van Laar JM (2013) The clinical utility of bone marker measurements in osteoporosis. J Transl Med 11:201CrossRefPubMedPubMedCentralGoogle Scholar
  46. Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S–1228S discussion 1229S–1231SPubMedGoogle Scholar
  47. Williams RA, Mamotte CD, Burnett JR (2008) Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev 29:31–41PubMedPubMedCentralGoogle Scholar
  48. Young B, Dao CN, Buchacz K, Baker R, Brooks JT, Investigators HIVOS (2011) Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis 52:1061–1068CrossRefPubMedGoogle Scholar
  49. Zeman J, Bayer M, Stepan J (1999) Bone mineral density in patients with phenylketonuria. Acta Paediatr 88:1348–1351CrossRefPubMedGoogle Scholar

Copyright information

© SSIEM and Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Kathryn E. Coakley
    • 1
    • 6
    Email author
  • Eric I. Felner
    • 2
  • Vin Tangpricha
    • 3
  • Peter W. F. Wilson
    • 4
  • Rani H. Singh
    • 5
  1. 1.Nutrition and Health Sciences and Molecules to Mankind Programs, Laney Graduate SchoolEmory UniversityAtlantaUSA
  2. 2.Division of Pediatric EndocrinologyEmory University School of MedicineAtlantaUSA
  3. 3.Division of Endocrinology, Metabolism and Lipids, Atlanta VA Medical CenterEmory University School of MedicineAtlantaUSA
  4. 4.Clinical Cardiovascular Research InstituteEmory University School of MedicineAtlantaUSA
  5. 5.Metabolic Nutrition Program, Department of Human GeneticsEmory University School of MedicineAtlantaUSA
  6. 6.Department of Individual, Family and Community EducationUniversity of New MexicoAlbuquerqueUSA

Personalised recommendations